Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice

Atherosclerosis

Volumn 144, Issue 2, 1999, Pages 315-321

  De Winther, Menno P J ^a,b   Gijbels, Marion J J ^a   Van Dijk, Ko Willems ^a   Van Gorp, Patrick J J ^a   Suzuki, Hiroshi ^c   Kodama, Tatsuhiko ^c   Frants, Rune R ^a   Havekes, Louis M ^a,b   Hofker, Marten H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apolipoprotein E; Atherosclerosis; Mouse models; Scavenger receptor

Indexed keywords

APOLIPOPROTEIN E3; CHOLESTEROL; SCAVENGER RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOAM CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR LESION;

ANIMALS; AORTA, THORACIC; APOLIPOPROTEIN E3; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; DIET, ATHEROGENIC; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RISK FACTORS; SCAVENGER RECEPTORS, CLASS B;

EID: 0032977440     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00332-3     Document Type: Article

References (31)

1. De Knijff P., Van den Maagdenberg A.M.J.M., Stalenhoef A.F.H., Gevers Leuven J.A., Demacker P.N.M., Kuyt L.P., Frants R.R., Havekes L.M. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigenerational pedigree. J. Clin. Invest. 88:1991;643-655.
2. Van den Maagdenberg A.M.J.M., De Knijff P., Stalenhoef A.F.H., Gevers Leuven J.A., Havekes L.M., Frants R.R. Apolipoprotein E3Leiden allele results from a partial gene duplication in exon 4. Biochem. Biophys. Res. Commun. 165:1989;851-857.
3. Van den Maagdenberg A.M.J.M., Hofker M.H., Krimpenfort P.J.A., De Bruijn I., Van Vlijmen B., Van der Boom H., Havekes L.M., Frants R.R. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 268:1993;10540-10545.
4. Van Vlijmen B.J.M., Van den Maagdenberg A.M.J.M., Gijbels M.J.J., Van der Boom H., HogenEsch H., Frants R.R., Hofker M.H., Havekes L.M. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 93:1994;1403-1410.
5. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369:1995;39-48.
6. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
7. Rosenfeld M.E., Palinski W., Yla-Herttuala S., Butler S., Witztum J.L. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:1990;336-349.
8. Freeman M., Ashkenas J., Rees D.J.G., Kingsley D.M., Copeland N.G., Jenkins N.A., Krieger M. An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc. Natl. Acad. Sci. USA. 87:1990;8810-8814.
9. Doi T., Higashino K., Kurihara Y., Wada Y., Miyazaki T., Nakamura H., Uesugi S., Imanishi T., Kawabe Y., Itakura H. et al. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J. Biol. Chem. 268(3):1993;2126-2133.
10. Emi M., Asaoka H., Matsumoto A., Itakura H., Kurihara Y., Wada Y., Kanamori H., Yazaki Y., Takahashi E., Lepert M. et al. Structure, organization, and chromosomal mapping of the human macrophage scavenger receptor gene. J. Biol. Chem. 268:1993;2120-2125.
11. Kodama T., Doi T., Suzuki H., Takahashi K., Wada Y., Gordon S. Collagenous macrophage scavenger receptors. Curr. Opin. Lipidol. 7(5):1996;287-291.
12. Geng Y.J., Holm J., Nygren S., Bruzelius M., Stemme S., Hansson G.K. Expression of the macrophage scavenger receptor in atheroma - Relationship to immune activation and the T-cell cytokine interferon-γ Arterioscler. Thromb. Vasc. Biol. 15:1995;1995-2002.
13. Matsumoto A., Naito M., Itakura H., Ikemoto S., Asaoka H., Hayakawa I., Kanamori H., Aburatani H., Takaku F., Suzuki H. et al. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87(23):1990;9133-9137.
14. 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. J. Clin. Invest. 93:1994;2014-2021.
15. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T. et al. A role for the macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386(6622):1997;292-296.
16. Freeman M., Ekkel Y., Rohrer L., Penman M., Freedman N.J., Chisolm G.M., Krieger M. Expression of type I and type II bovine scavenger receptors in chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88:1991;4931-4935.
17. Yla-Herttuala S., Rosenfeld M.E., Parthasarathy S., Glass C.K., Sigal E., Witztum J.L., Steinberg D. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:1990;6959-6963.
18. Groot P.H.E., Van Vlijmen B.J.M., Benson G.M., Hofker M.H., Schiffelers R., Vidgeonhart M., Havekes L.M. Quantitative assessment of aortic atherosclerosis in APOE3Leiden transgenic mice and its relationship to serum cholesterol exposure. Arterioscler. Thromb. Vasc. Biol. 16(8):1996;926-933.
19. Stary H.C., Chandler A.B., Dinsmore R.E., Fuster V., Glagov S., Insull W. Jr., Rosenfeld M.E., Schwartz C.J., Wagner W.D., Wissler R.W. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler. Thromb. Vasc. Biol. 15(9):1995;1512-1531.
20. 2-macroglobulin receptor (A2MR)/LDL receptor-related protein (LRP) gene. Hum. Mol. Genet. 3:1994;215.
21. Paigen B., Morrow A., Holmes P.A., Mitchel D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
22. Kraal G., Rep M., Janse M. Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand. J. Immunol. 26(6):1987;653-661.
23. Van Vliet E., Melis M., Foidart J.M., Van Ewijk W. Reticular fibroblasts in peripheral lymphoid organs identified by a monoclonal antibody. J. Histochem. Cytochem. 34(7):1986;883-890.
24. Bellosta S., Mahley R.W., Sanan D.A., Murata J., Newland D.L., Taylor J.M., Pitas R.E. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96:1995;2170-2179.
25. Shimano H., Ohsuga J., Shimada M., Namba Y., Gotoda T., Harada K., Katsuki M., Yazaki Y., Yamada N. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J. Clin. Invest. 95:1995;469-476.
26. Fazio S., Babaev V.R., Murray A.B., Hasty A.H., Carter K.J., Gleaves L.A., Atkinson J., Linton M.F. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc. Natl. Acad. Sci. USA. 94(9):1997;4647-4652.
27. Yla Herttuala S. Expression of lipoprotein receptors and related molecules in atherosclerotic lesions. Curr. Opin. Lipidol. 7(5):1996;292-297.
28. Van Dijk K.W., van Vlijmen B.J., Van der Zee A., van't Hof B., Van der Boom H., Kobayashi K., Chan L., Havekes L.M., Hofker M.H. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirusmediated gene transfer of the VLDL receptor. Arterioscler. Thromb. Vasc. Biol. 18(1):1998;7-12.
29. Van Vlijmen B.J.M., Willems van Dijk K., Van't Hof H.B., Van Gorp P.J.J., Van der Zee A., Van der Boom H., Breuer M.L., Hofker M.H., Havekes L.M. In the absence of endogenous mouse apolipoprotein E, apolipoprotein E2(Arg-158→Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E3Leiden transgenic mice. J. Biol. Chem. 271(48):1996;30595-30602.
30. Thiery J., Teupser D., Walli A.K., Ivandic B., Nebendahl K., Stein O., Stein Y., Seidel D. Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis. 121(1):1996;63-73.
31. Teupser D., Thiery J., Walli A.K., Seidel D. Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim. Biophys. Acta. 1303(3):1996;193-198.